Literature DB >> 11959786

Bretylium or 6-OHDA-resistant, action potential-evoked Ca2+ transients in varicosities of the mouse vas deferens.

V Margaret Jackson1, Tom C Cunnane.   

Abstract

Action potential-evoked calcium transients in varicosities in mouse vas deferens were monitored using laser scanning confocal microscopy. Their significance was examined by comparison with excitatory junction potentials (EJPs) and neurogenic contractions, both indirect measurements of transmitter release. Bretylium abolished EJPs, as well as the ATP and NA-mediated phases of contraction. However, bretylium revealed a prominent late component of contraction that was atropine-sensitive. Bretylium abolished calcium transients in 21%, enhanced in 16% and had no effect in 63% of varicosities examined. Pre-treatment with 6-OHDA reduced NA levels to below detectable levels but many strings of varicosities still responded to nerve impulses with 'normal' calcium transients. Varicosities in which calcium transients were abolished by these agents were sympathetic. The identity of those varicosities in which calcium transients were resistant to bretylium (sympathetic but no uptake-1 sites, parasympathetic, sensory) remains to be established.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11959786      PMCID: PMC1573333          DOI: 10.1038/sj.bjp.0704677

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  Characterization of action potential-evoked calcium transients in mouse postganglionic sympathetic axon bundles.

Authors:  V M Jackson; S J Trout; K L Brain; T C Cunnane
Journal:  J Physiol       Date:  2001-11-15       Impact factor: 5.182

2.  Calcium in sympathetic varicosities of mouse vas deferens during facilitation, augmentation and autoinhibition.

Authors:  K L Brain; M R Bennett
Journal:  J Physiol       Date:  1997-08-01       Impact factor: 5.182

3.  The selective accumulation of bretylium in sympathetic ganglia and their postganglionic nerves.

Authors:  A L BOURA; F C COPP; W G DUNCOMBE; A F GREEN; A McCOUBREY
Journal:  Br J Pharmacol Chemother       Date:  1960-06

4.  Electrical activity at the sympathetic neuroeffector junction in the guinea-pig vas deferens.

Authors:  J A Brock; T C Cunnane
Journal:  J Physiol       Date:  1988-05       Impact factor: 5.182

5.  Activity-dependent intracellular Ca2+ transients in unmyelinated nerve fibres of the isolated adult rat vagus nerve.

Authors:  J Wächtler; C Mayer; P Grafe
Journal:  Pflugers Arch       Date:  1998-04       Impact factor: 3.657

Review 6.  Histochemical determination of neurotransmitter distribution.

Authors:  T G Hökfelt; A S Ljungdahl
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1972

7.  Norepinephrine concentrating mechanisms in sympathetic nerve trunks.

Authors:  L Stjärne; R H Roth; F E Bloom; N J Giarman
Journal:  J Pharmacol Exp Ther       Date:  1970-01       Impact factor: 4.030

8.  Actions of alpha, beta-methylene ATP and 6-hydroxydopamine on sympathetic neurotransmission in the vas deferens of the guinea-pig, rat and mouse: support for cotransmission.

Authors:  R J Allcorn; T C Cunnane; K Kirkpatrick
Journal:  Br J Pharmacol       Date:  1986-12       Impact factor: 8.739

9.  Noradrenergic, purinergic, and cholinergic transmission in the mouse vas deferens: influence of field-stimulation parameters, reserpinization, 6-hydroxydopamine and 4-aminopyridine.

Authors:  M Kaschube; G Zetler
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

10.  The uptake and release of radioactive noradrenaline by the splenic nerves of cats.

Authors:  J S Gillespie; S M Kirpekar
Journal:  J Physiol       Date:  1966-11       Impact factor: 5.182

View more
  4 in total

1.  Do fluorescent drugs show you more than you wanted to know?

Authors:  J C McGrath; C J Daly
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

2.  Cholinergic innervation of the mouse isolated vas deferens.

Authors:  Alina M Cuprian; Pravesh Solanki; Margaret V Jackson; Thomas C Cunnane
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

3.  Cholinergic innervation of the guinea-pig isolated vas deferens.

Authors:  Pravesh Solanki; Alina M Cuprian-Beltechi; Thomas C Cunnane
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-09       Impact factor: 3.000

4.  Bretylium abolishes neurotransmitter release without necessarily abolishing the nerve terminal action potential in sympathetic terminals.

Authors:  K L Brain; T C Cunnane
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.